Tag: immunoassay market share

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Immunoassay Market Size, Value And Growth Trajectory Through 2030

The immunoassay market has experienced substantial growth in recent years. It is projected to expand from $37.32 billion in 2025 to $40.07 billion in 2026, registering a compound annual growth rate (CAGR) of 7.4%. The expansion observed historically can be ascribed to the increasing prevalence of infectious and chronic diseases, higher volumes of clinical laboratory testing, the broad adoption of ELISA-based diagnostics, growth in pharmaceutical research activities, and a rising demand for early disease detection.

The immunoassay market is set to experience substantial expansion over the next few years. Its valuation is projected to reach $52.83 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This growth during the forecast period is primarily driven by factors such as the escalating demand for rapid diagnostics, increased investments in personalized medicine, the expansion of decentralized testing models, a wider adoption of digital laboratory workflows, and a greater focus on companion diagnostics. Significant trends anticipated in this period encompass the growing acceptance of high-sensitivity immunoassay kits, the increased utilization of automated immunoassay analyzers, rising demand for point-of-care immunoassay testing, the expansion of multiplex immunoassay platforms, and improved integration of data management software.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=69950760&type=smp&name=Immunoassay%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Immunoassay Market Opportunity Drivers: What’s Unlocking New Revenue Potential?

The immunoassay market is anticipated to experience growth due to the escalating numbers of infectious and chronic illnesses. These refer to diseases caused by pathogens or enduring medical conditions that demand continuous monitoring, diagnosis, and management. The rise in infectious and chronic illnesses is attributed to increased exposure to environmental pollutants, which compromise immunity and elevate vulnerability to disease. The immunoassay market is seeing heightened demand as the swift increase in these illnesses prompts companies to integrate advanced diagnostic tools crucial for early detection, disease surveillance, and precise clinical decision-making. For instance, in June 2025, the UK Health Security Agency (UKHSA), a United Kingdom-based government public health agency, indicated that reported Campylobacter cases in England climbed from 60,055 in 2023 to 70,352 cases in 2024, marking a rise of 10,297 cases (17.1%) and an increase in the reporting rate from 104.1 to 121.9 per 100,000 population. Therefore, the expanding prevalence of infectious and chronic illnesses is a significant driver for the immunoassay market.

Immunoassay Market Segmentation: How Does The Market Break Down By Category?

The immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End User: Research And Academic Laboratories, Pharmaceutical And Biotechnology Companies And CROs, Hospitals And Clinics, Clinical Laboratories

Subsegments:

1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents

2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers

3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

Immunoassay Market Innovation Trends Shaping Future Development

Leading companies in the immunoassay market are launching innovative immunoassay analyzers to secure a competitive advantage. Immunoassay analyzers are laboratory instruments designed to automate and simplify the detection and measurement of biological molecules, such as proteins or hormones, through immunological reactions. For example, in May 2023, Beckman Coulter Diagnostics, a US-based firm that develops products to simplify, automate, and innovate complex biomedical testing, introduced the DxI 9000 Access Immunoassay Analyzer. The DxI 9000 Access Immunoassay Analyzer addresses clinical laboratories’ needs for speed, reliability, reproducibility, quality, and an expanded test menu. It has demonstrated the capacity to develop increasingly sensitive and clinically relevant assays, thereby amplifying the effectiveness of new pharmaceutical therapies and ultimately improving patient health outcomes. This system incorporates innovations such as advanced analyte processing and detection technology, precision sensors, intelligent algorithms, and remote real-time system monitoring, making it the only immunoassay analyzer system that does not require daily maintenance.

Immunoassay Market Competitive Analysis Of Leading Industry Participants

Major companies operating in the immunoassay market are Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

View The Full Immunoassay Market Report:

https://thebusinessresearchcompany.com/report/immunoassay-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Immunoassay Market Geographic Spread And Regional Opportunities

North America was the largest region in the immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Expansion Is Expected For The Immunoassay Market Over The Forecast Period?

The immunoassay market has demonstrated substantial expansion in recent years, and this positive trend is set to continue. It is forecast to increase from $37.32 billion in 2025 to $40.07 billion by 2026, achieving a compound annual growth rate (CAGR) of 7.4%. The market’s past growth has been driven by several key factors, including the increasing prevalence of infectious and chronic diseases, higher volumes in clinical laboratory testing, the broad acceptance of elisa-based diagnostics, the expansion of pharmaceutical research activities, and a greater demand for early disease detection.

The immunoassay market is projected to experience robust expansion over the coming years, reaching a valuation of $52.83 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during the forecast period stems from several factors, including the escalating need for rapid diagnostic solutions, increased capital allocation towards personalized medicine, the proliferation of decentralized testing approaches, the expanding integration of digital processes in laboratories, and a heightened emphasis on companion diagnostics. Key developments expected within this period involve the greater uptake of high-sensitivity immunoassay kits, the increasing deployment of automated immunoassay analyzers, a rising call for point-of-care immunoassay examinations, the broadening scope of multiplex immunoassay technologies, and improved incorporation of data management software.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9838&type=smp

Which Growth Factors Are Strengthening The Immunoassay Market Landscape?

The anticipated expansion of the immunoassay market is linked to the growing incidence of infectious and chronic diseases. These illnesses encompass diseases stemming from pathogens or persistent medical conditions necessitating continuous oversight, diagnosis, and treatment. An uptick in environmental pollutant exposure, which compromises immunity and heightens disease vulnerability, is contributing to their rise. The fast spread of infectious and chronic conditions is boosting demand in the immunoassay market, prompting companies to implement sophisticated diagnostic instruments for prompt detection, disease monitoring, and precise clinical judgments. As an illustration, the UK Health Security Agency (UKHSA), a government public health agency in the United Kingdom, reported in June 2025 that Campylobacter cases in England rose from 60,055 in 2023 to 70,352 in 2024, marking an increase of 10,297 cases (17.1%) and a jump in the reporting rate from 104.1 to 121.9 per 100,000 population. Consequently, the expanding prevalence of infectious and chronic illnesses is fueling the need for the immunoassay market.

What Are The Major Segment Categories Within The Immunoassay Market?

The immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End User: Research And Academic Laboratories, Pharmaceutical And Biotechnology Companies And CROs, Hospitals And Clinics, Clinical Laboratories

Subsegments:

1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents

2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers

3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

What Trends Are Influencing The Immunoassay Market Outlook?

Prominent companies within the immunoassay market are launching cutting-edge immunoassay analyzers to gain a competitive advantage. These laboratory instruments are specifically designed to automate and simplify the detection and measurement of biological molecules, such as proteins or hormones, by employing immunological reactions. For example, in May 2023, Beckman Coulter Diagnostics, a US-based company focused on creating products that simplify, automate, and innovate complex biomedical testing, introduced the DxI 9000 Access Immunoassay Analyzer. The DxI 9000 Access Immunoassay Analyzer is engineered to satisfy the needs of clinical laboratories regarding speed, dependability, consistency, quality, and the expansion of available tests. It has shown the ability to develop increasingly sensitive and clinically relevant assays, which in turn amplifies the effectiveness of new pharmaceutical therapies and ultimately enhances patient outcomes. This system incorporates innovations like advanced analyte processing and detection technology, precise sensors, intelligent algorithms, and remote real-time system monitoring, distinguishing itself as the only immunoassay analyzer system that requires no daily maintenance.

Who Are The Businesses Driving Activity In The Immunoassay Market?

Major companies operating in the immunoassay market are Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

Access The Complete Immunoassay Market Report:

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Which Area Represents The Largest Portion Of The Immunoassay Market?

North America was the largest region in the immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Immunoassay Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Browse Through More Reports Similar to the Global Immunoassay Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunomodulator Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunomodulator-global-market-report

Immune Health Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/immune-health-supplements-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Immunoassay Market In 2026 And 2030?

The immunoassay market has experienced robust expansion in recent years. Projections indicate it will expand from $37.32 billion in 2025 to reach $40.07 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 7.4%. Historically, this growth has been driven by factors such as the increasing prevalence of infectious and chronic diseases, higher clinical laboratory testing volumes, the broad acceptance of elisa-based diagnostics, a surge in pharmaceutical research activities, and the escalating need for early disease detection.

The immunoassay market size is projected to experience substantial expansion in the coming years, with an anticipated increase to $52.83 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. This growth during the forecast period is primarily driven by several factors, including the escalating demand for rapid diagnostic solutions, greater investments in personalized medicine, the broadening of decentralized testing approaches, the expanding integration of digital laboratory workflows, and a heightened emphasis on companion diagnostics. Key trends expected over the forecast horizon encompass the increasing uptake of high-sensitivity immunoassay kits, the greater utilization of automated immunoassay analyzers, the rising need for point-of-care immunoassay testing, the development of multiplex immunoassay platforms, and improved integration of data management software.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9838&type=smp

Which Key Factors Are Driving The Immunoassay Market Growth?

A growing prevalence of infectious and chronic diseases is projected to drive the expansion of the immunoassay market. These conditions are defined as ailments originating from pathogens or persistent health issues demanding continuous oversight, diagnosis, and care. Their increase is linked to heightened exposure to environmental pollutants, which compromises immune systems and raises vulnerability to diseases. Consequently, the immunoassay market is experiencing higher demand, as the swift spread of these illnesses compels businesses to utilize sophisticated diagnostic methods for prompt detection, disease tracking, and precise clinical judgments. For illustration, data from June 2025 by the UK Health Security Agency (UKHSA), a public health entity in the United Kingdom, indicated that reported Campylobacter cases in England rose from 60,055 in 2023 to 70,352 in 2024. This signifies an increase of 10,297 cases (17.1%) and an elevated reporting rate from 104.1 to 121.9 per 100,000 population. Thus, the growing incidence of infectious and chronic diseases is fueling the demand within the immunoassay market.

What Are The Different Segment Types In The Immunoassay Market Segment Breakdown?

The immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End User: Research And Academic Laboratories, Pharmaceutical And Biotechnology Companies And CROs, Hospitals And Clinics, Clinical Laboratories

Subsegments:

1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents

2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers

3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

Which Trends Are Guiding The Direction Of The Immunoassay Market?

Major companies in the immunoassay market are launching innovative immunoassay analyzers to gain a competitive advantage. These laboratory instruments are designed to automate and facilitate the detection and quantification of biological molecules, such as proteins or hormones, through immunological reactions. For instance, in May 2023, Beckman Coulter Diagnostics, a US-based company focused on simplifying, automating, and innovating complex biomedical testing, introduced the DxI 9000 Access Immunoassay Analyzer. The DxI 9000 Access Immunoassay Analyzer addresses the demands of clinical laboratories regarding speed, reliability, reproducibility, quality, and menu expansion. It has demonstrated the capability to develop increasingly sensitive and clinically relevant assays, thereby amplifying the impact of new pharmaceutical therapies and ultimately improving patient outcomes. Its innovations include new analyte processing and detection technology, precision sensors, smart algorithms, and remote real-time system monitoring, making it the only immunoassay analyzer system that requires no daily maintenance.

Who Are The Well-Known Companies In The Immunoassay Market?

Major companies operating in the immunoassay market are Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

Get The Full Immunoassay Market Report:

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Which Region Is The Largest In The Immunoassay Market?

North America was the largest region in the immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Immunoassay Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=9838&type=smp

Browse Through More Reports Similar to the Global Immunoassay Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunomodulator Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunomodulator-global-market-report

Immune Health Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/immune-health-supplements-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Immunoassay Market Projected To Become By 2030 Based On Its 2026 Valuation?

The immunoassay market has shown substantial expansion in recent years. Its valuation is anticipated to rise from $37.32 billion in 2025 to $40.07 billion in 2026, progressing at a compound annual growth rate (CAGR) of 7.4%. This historical growth can be attributed to the increasing incidence of infectious and chronic conditions, a surge in clinical laboratory testing volumes, the extensive embrace of ELISA-based diagnostics, the broadening scope of pharmaceutical research efforts, and the escalating demand for prompt disease detection.

The immunoassay market size is projected to experience robust growth in the upcoming years. It is set to expand to $52.83 billion in 2030, achieving a compound annual growth rate (CAGR) of 7.2%. This increase during the forecast period can be attributed to factors such as the escalating demand for rapid diagnostics, greater investments in personalized medicine, the expansion of decentralized testing models, the increasing adoption of digital laboratory workflows, and a heightened focus on companion diagnostics. Significant trends anticipated within the same timeframe include the growing acceptance of high-sensitivity immunoassay kits, the rising deployment of automated immunoassay analyzers, an increasing need for point-of-care immunoassay testing, the expansion of multiplex immunoassay platforms, and improved integration of data management software.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9838&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Immunoassay Market?

The growing incidence of infectious and chronic diseases is projected to fuel the expansion of the immunoassay market in the future. These conditions encompass illnesses stemming from pathogens or enduring health issues necessitating continuous oversight, identification, and care. Their rise is attributed to heightened exposure to environmental contaminants, which compromises immune systems and elevates disease vulnerability. Consequently, the immunoassay market is experiencing higher demand, driven by the swift increase in these illnesses, prompting businesses to integrate sophisticated diagnostic instruments for prompt detection, disease monitoring, and precise clinical judgments. For example, the UK Health Security Agency (UKHSA), a public health body based in the United Kingdom, reported in June 2025 that Campylobacter cases in England escalated from 60,055 in 2023 to 70,352 in 2024. This represented an increase of 10,297 cases, or 17.1%, with the reporting rate climbing from 104.1 to 121.9 per 100,000 population. Thus, the growing prevalence of infectious and chronic illnesses is fueling the demand within the immunoassay market.

What Segment Groups Are Identified Within The Immunoassay Market?

The immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End User: Research And Academic Laboratories, Pharmaceutical And Biotechnology Companies And CROs, Hospitals And Clinics, Clinical Laboratories

Subsegments:

1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents

2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers

3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

What Trends Are Advancing Progress In The Immunoassay Market?

Leading companies in the immunoassay market are introducing advanced immunoassay analyzers to gain a competitive advantage. Immunoassay analyzers are sophisticated laboratory instruments designed to automate and streamline the detection and measurement of biological molecules, such as proteins or hormones, by employing immunological reactions. For instance, in May 2023, Beckman Coulter Diagnostics, a US-based company specializing in products that simplify, automate, and innovate complex biomedical testing, launched its DxI 9000 Access Immunoassay Analyzer. The DxI 9000 Access Immunoassay Analyzer is engineered to fulfill clinical laboratories’ needs for speed, reliability, reproducibility, quality, and an expanded test menu. It has demonstrated the ability to develop increasingly sensitive and clinically relevant assays, enhancing the effect of new pharmaceutical treatments and ultimately improving patient outcomes. This system incorporates innovations such as new analyte processing and detection technology, precision sensors, smart algorithms, and remote real-time system monitoring, and stands out as the only immunoassay analyzer system requiring no daily maintenance.

Which Companies Hold Significant Positions In The Immunoassay Market?

Major companies operating in the immunoassay market are Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

Read the full immunoassay market report here:

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Which Regions Are Projected To Dominate The Immunoassay Market In The Coming Years?

North America was the largest region in the immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Immunoassay Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9838&type=smp

Browse Through More Reports Similar to the Global Immunoassay Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunomodulator Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunomodulator-global-market-report

Immune Health Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/immune-health-supplements-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Immunoassay Market covering 2026–2035?

The immunoassay market size has experienced robust growth in recent years. Looking ahead, this market is projected to expand from $37.32 billion in 2025 to $40.07 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.4%. Historically, this expansion has been driven by factors such as the increasing prevalence of infectious and chronic diseases, a surge in clinical laboratory testing volumes, the broad use of ELISA-based diagnostics, intensified pharmaceutical research endeavors, and a heightened need for early disease detection.

The immunoassay market is expected to show significant growth in the upcoming years, with its size projected to reach $52.83 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This projected growth is attributed to factors such as the increasing demand for rapid diagnostics, rising investments in personalized medicine, the expansion of decentralized testing models, the growing adoption of digital laboratory workflows, and an increasing focus on companion diagnostics. Major trends anticipated during this period include the wider adoption of high-sensitivity immunoassay kits, increased utilization of automated immunoassay analyzers, a growing demand for point-of-care immunoassay testing, the expansion of multiplex immunoassay platforms, and enhanced integration of data management software.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9838&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Immunoassay Market?

The anticipated growth of the immunoassay market is set to be propelled by the rising prevalence of infectious and chronic illnesses. These conditions are defined as diseases caused by pathogens or long-term medical ailments requiring continuous monitoring, diagnosis, and management. An increase in exposure to environmental pollutants, which weaken immunity and heighten susceptibility to disease, is contributing to the rise of infectious and chronic illnesses. As a result, the immunoassay market is experiencing elevated demand, with the rapid expansion of these illnesses prompting companies to adopt advanced diagnostic tools that facilitate early detection, disease surveillance, and accurate clinical decision-making. For instance, in June 2025, the UK Health Security Agency (UKHSA), a United Kingdom-based government public health agency, reported that the number of Campylobacter cases in England climbed from 60,055 in 2023 to 70,352 cases in 2024. This signifies an increase of 10,297 cases (17.1%) and an uptick in the reporting rate from 104.1 to 121.9 per 100,000 population. Consequently, the increasing numbers of infectious and chronic illnesses are a key driver for the immunoassay market.

What Leading Segments Are Studied In The Immunoassay Market?

The immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End User: Research And Academic Laboratories, Pharmaceutical And Biotechnology Companies And CROs, Hospitals And Clinics, Clinical Laboratories

Subsegments:

1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents

2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers

3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

Which Market Trends Are Opening Growth Opportunities In The Immunoassay Market?

Leading companies active in the immunoassay market are introducing innovative immunoassay analyzers to secure a competitive edge. Immunoassay analyzers are sophisticated laboratory instruments designed to automate and streamline the detection and quantification of biological molecules, such as proteins or hormones, by leveraging immunological reactions. A significant development occurred in May 2023, when Beckman Coulter Diagnostics, a US-based company focused on simplifying, automating, and innovating complex biomedical testing, unveiled the DxI 9000 Access Immunoassay Analyzer. The DxI 9000 Access Immunoassay Analyzer addresses the needs of clinical laboratories for enhanced speed, reliability, reproducibility, quality, and menu expansion. It has shown the capacity to develop increasingly sensitive and clinically relevant assays, thus amplifying the effect of new pharmaceutical therapies and ultimately improving patient outcomes. This system features advancements like new analyte processing and detection technology, precision sensors, smart algorithms, and remote real-time system monitoring, notably being the sole immunoassay analyzer system that requires no daily maintenance.

Which Major Industry Participants Are Leading The Immunoassay Market Growth?

Major companies operating in the immunoassay market are Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Immunoassay Market?

North America was the largest region in the immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Immunoassay Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9838&type=smp

Browse Through More Reports Similar to the Global Immunoassay Market 2026, By The Business Research Company

Immunohematology Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunomodulator Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunomodulator-global-market-report

Immune Health Supplements Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/immune-health-supplements-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the immunoassay market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Immunoassay Market And What Value Is Projected For 2029?

The immunoassay market size has shown consistent expansion in recent years. It is anticipated to expand from $35.81 billion in 2024 to $37.32 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.2%. The increase observed in the historic period can be linked to aspects like disease prevalence, an aging population, infectious disease outbreaks, the adoption of point-of-care testing, and increased research funding.

The immunoassay market is anticipated to experience robust expansion over the coming years, with its valuation projected to reach $49.4 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.3%. This projected growth during the forecast period is largely due to factors such as personalized medicine, the broadening of emerging markets, enhanced pandemic preparedness, advancements in cancer diagnostics, and the increasing adoption of home-based testing. Key developments expected during this period encompass initiatives for regulatory harmonization, the emergence of multipurpose immunoassays, personalized assay services, the incorporation of wearable technology, and the miniaturization of assay systems.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9838&type=smp

What Factors Are Boosting The Immunoassay Market?

The anticipated expansion of the immunoassay market is linked to the rising prevalence of infectious and chronic diseases in the foreseeable future. Chronic conditions are generally defined as those lasting a year or longer, necessitating ongoing medical attention, limiting daily functions, or a combination of these factors. Infectious diseases, on the other hand, originate from agents like bacteria, viruses, fungi, or parasites; many such organisms naturally reside within or on the human body, and various infectious illnesses can spread between individuals. Immunoassay technology plays a crucial role in identifying a range of both infectious and chronic health issues. For example, a 2023 report from the National Institutes of Health (NIH), a US-based biomedical research agency, projects a significant increase in the United States. It forecasts that the number of individuals aged 50 and older suffering from at least one chronic illness will climb by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Furthermore, the population experiencing multimorbidity is projected to increase by 91.16%, growing from 7.8304 million in 2020 to 14.968 million in 2050. Consequently, the growing incidence of infectious and chronic illnesses serves as a primary driver for the market.

What Are The Core Segmentation Criteria In The Immunoassay Market?

The immunoassaymarket covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End User: Research And Academic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies And CROs, Blood Banks, Hospitals And Clinics, Clinical Laboratories

Subsegments:

1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents

2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers

3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

Which Emerging Trends Are Reshaping The Immunoassay Market Landscape?

Product innovation represents a significant trend gaining traction in the immunoassay market. Leading companies operating within the immunoassay market are concentrating on developing advanced products to enhance their market standing. For instance, in November 2022, Getein Biotech Inc., a China-based biotechnological company involved in the manufacturing, sales, service, and research and development of in vitro diagnostic reagents and tools, unveiled MAGICL 6000 at MEDICA 2022. The MAGICL 6000 is a portable, cutting-edge chemiluminescence immunoassay analyzer, presented as an optimal choice for laboratories with mid- to high-workflow requirements seeking a one-step chemiluminescence solution. This instrument is notably efficient and compact, facilitates completely automated operation, and possesses the quickest assessment frequency among devices of its size.

Which Players Are Shaping The Competitive Landscape Of The ImmunoassayXX Market?

Major companies operating in the immunoassay market include Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

What Regional Trends Are Shaping Growth In The Immunoassay Market?

North America was the largest region in the immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9838&type=smp

Browse Through More Reports Similar to the Global Immunoassay Market 2025, By The Business Research Company

Neurology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Neurodegenerative Disorder Therapeutic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Neurophysiology Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Immunoassay Industry Expected To Reach By 2029, Starting From 2025 Levels?

Recent years have shown consistent expansion within the immunoassay market, projected to increase from its 2024 valuation of $35.81 billion to reach $37.32 billion in 2025, reflecting a 4.2% CAGR; this upward trajectory during the past period stemmed from factors such as the rising incidence of various diseases, an expanding elderly demographic, sudden outbreaks of infectious ailments, the advancement of point-of-care diagnostic procedures, and boosted financial support for research endeavors.

Projections indicate robust expansion for the immunoassay sector over the forthcoming years, with its valuation set to reach $49.4 billion by 2029, reflecting a compound annual growth rate (CAGR) of 7.3%. This upswing during the forecasted timeframe is fundamentally driven by advances in personalized medicine, the broadening reach into developing economies, heightened focus on pandemic readiness, advancements in cancer diagnosis, and a discernible movement towards self-administered testing at home. Key developments anticipated throughout this period encompass the drive toward standardizing regulations across different regions, the development of immunoassays capable of multiple functions simultaneously, bespoke services for assay development, incorporating assays with wearable technology, and the continued reduction in the physical size of diagnostic tests.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9838&type=smp

Which Drivers Are Shaping The Immunoassay Industry’s Market Share?

The rising prevalence of both long-term conditions and acute infections is anticipated to be a primary catalyst for the expansion of the immunoassay market moving forward. Chronic ailments are generally defined as conditions lasting a year or longer that either demand ongoing medical intervention, impede daily functioning, or both, while infectious diseases stem from pathogenic agents like microbes, viral particles, fungal spores, or parasites; the human body hosts a vast array of such organisms, and the contagiousness of many infectious diseases allows for interpersonal transmission. Immunoassays serve as a crucial tool for identifying a spectrum of these infectious and chronic health issues, evidenced by projections from the National Institutes of Health (NIH), an American biomedical research entity, indicating that within the United States by 2050, the count of individuals aged 50 and above suffering from a minimum of one chronic disease is projected to nearly double, increasing by 99.5% from 71.522 million documented in 2020 to 142.66 million; furthermore, the population experiencing multimorbidity is slated for an 91.16% escalation, moving from 7.8304 million in 2020 to 14.968 million by 2050, thus cementing the growing burden of infectious and chronic conditions as a significant market stimulant.

What Are The Major Segments Identified In The Immunoassay Market?

The immunoassaymarket covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End User: Research And Academic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies And CROs, Blood Banks, Hospitals And Clinics, Clinical Laboratories

Subsegments:

1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents

2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers

3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

Which Competitive Trends Are Defining The Immunoassay Market Structure?

A significant movement within the immunoassay sector revolves around enhancing products, with leading participants striving to improve their standing through the introduction of novel offerings. A case in point is the introduction by Getein Biotech Inc., the China-based developer, manufacturer, seller, and service provider for in vitro diagnostic tools and reagents, of the MAGICL 6000 at the MEDICA 2022 exhibition in November 2022. This device represents a state-of-the-art, portable chemiluminescence immunoassay analyzer, perfectly suited for facilities requiring a streamlined, single-step chemiluminescence process amidst medium to high testing volumes. Characterized by its compact design and exceptional operational speed, this unit provides fully automated functionality, boasting the fastest testing throughput available for analyzers of its compact dimensions.

Who Are The Key Multinational Companies Dominating The Immunoassay Market?

Major companies operating in the immunoassay market include Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

How Does The Immunoassay Market Perform Across Key Geographic Regions?

North America was the largest region in the immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Immunoassay Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9838&type=smp

Browse Through More Reports Similar to the Global Immunoassay Market 2025, By The Business Research Company

Neurology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Neurodegenerative Disorder Therapeutic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Neurophysiology Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Immunoassay Market In The Coming Years?

The size of the immunoassay market has been incrementally increasing in the past few years. The market will expand from $35.81 billion in 2024 to $37.32 billion in 2025, registering a compound annual growth rate (CAGR) of 4.2%. This growth during the historical period can be linked to the prevalence of diseases, an aging population, the occurrence of infectious disease outbreaks, the adoption of point-of-care testing, and the augmentation of research funding.

In the coming years, a significant expansion is anticipated in the immunoassay market size. The market growth is expected to reach $49.4 billion by 2029, with a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this growth during the forecast period include the rise of personalized medicine, growth in emerging markets, preparation for pandemics, cancer diagnostic advancements, and a switch to home-based testing. The forecast period will also witness several trends including efforts in regulatory harmonization, multipurpose immunoassays, tailored assay services, incorporation with wearable devices, and assay miniaturization.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9838&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Immunoassay Market?

The escalating prevalence of infectious and chronic diseases is projected to spur the growth trajectory of the immunoassay market in the forthcoming period. Chronic diseases generally linger for over a year and necessitate consistent medical attention, limit day-to-day activities, or both. Infectious diseases, on the other hand, are contracted from organisms such as bacteria, viruses, fungi, or parasites. A multitude of such organisms inhabit the human body and many infectious diseases can be passed from one individual to another. The immunoassay method is used to identify a variety of infectious and chronic conditions. For example, a study by the National Institutes of Health (NIH), a US-based organization specializing in biomedical research, forecasts that the population of individuals aged 50 and above with at least one chronic ailment will surge by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050 in the United States. Furthermore, there will be a projected increase of 91.16% in the number of persons with multiple diseases, rising from 7.8304 million in 2020 to 14.968 million in 2050. Consequently, the rising prevalence of infectious and chronic diseases is fueling the market’s expansion.

Which Sub-Segments Are Driving Growth Within The Immunoassay Market?

The immunoassaymarket covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End User: Research And Academic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies And CROs, Blood Banks, Hospitals And Clinics, Clinical Laboratories

Subsegments:

1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents

2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers

3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

What Future-Focused Trends Are Anticipated In The Immunoassay Market?

The prevailing trend in the immunoassay market is centered around product innovation. The major market players are striving to create groundbreaking products to fortify their standing in the market. To illustrate, Getein Biotech Inc., a biotechnological firm based in China that manufactures, sells, and carries out research and development of in vitro diagnostic reagents and instruments, unveiled MAGICL 6000 at the MEDICA 2022 event in November 2022. This advanced, portable chemiluminescence immunoassay analyzer is an optimal choice for laboratories necessitating a one-time chemiluminescence solution, and it is particularly suitable for those with medium to high workflow requirements. It stands out for its exceptional efficiency, compact size, fully automated functionality, and possesses the fastest evaluation rate among devices of similar size.

Which Players Are Shaping The Competitive Landscape Of The Immunoassay Market?

Major companies operating in the immunoassay market include Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

How Do Regional Dynamics Influence The Immunoassay Market Performance?

North America was the largest region in the immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9838&type=smp

Browse Through More Reports Similar to the Global Immunoassay Market 2025, By The Business Research Company

Neurology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Neurodegenerative Disorder Therapeutic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Neurophysiology Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Immunoassay Market From 2025 To 2029?

In recent times, there has been a consistent expansion of the immunoassay market size. The forecasted growth is from $35.81 billion in 2024 to $37.32 billion in 2025, representing a compound annual growth rate (CAGR) of 4.2%. Factors such as disease prevalence, an aging population, outbreaks of infectious diseases, point-of-care testing, and enhanced research funding have contributed to the growth observed in the historical period.

The market size of immunoassays is anticipated to witness significant expansion in the coming years, flourishing to $49.4 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 7.3%. The anticipated growth during the forecast period can be credited to factors such as advancement in personalized medicine, growing presence in emerging markets, readiness for pandemics, cancer detection mechanisms, and transition towards at-home testing. Notable trends in the forecast duration include efforts towards regulatory harmonization, multi-use immunoassays, personalized assay solutions, association with wearable technologies, and downsizing of assays.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9838&type=smp

What Are the Core Market Drivers Propelling Growth in the Immunoassay Industry?

Anticipated growth in the immunoassay market is largely due to the rise in infectious and chronic health conditions. Typically defined as conditions that last a year or more and require regular medical attention, limit daily function, or both, chronic illnesses are on an upward trend. Furthermore, infectious diseases, resulting from organisms like bacteria, viruses, fungi, or parasites, are also contributing to this trend. Many of these organisms live on the human body and can cause various illnesses. Some of these infectious diseases can be transmitted between individuals. Immunoassays have a vital role in identifying these types of diseases. For example, research conducted by the American biomedical research organization, the National Institutes of Health (NIH), suggests an increase of 99.5% (from 71.522 million in 2020 to 142.66 million in 2050) in the number of individuals aged 50 or older with at least one chronic illness in the United States. Simultaneously, they project an increase from 7.8304 million in 2020 to 14.968 million in 2050 in people suffering from multiple health conditions, marking a 91.16% rise. Hence, the growing prevalence of infectious and chronic diseases is fueling the immunoassay market’s growth.

How Is the Immunoassay Market Segmented?

The immunoassaymarket covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End User: Research And Academic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies And CROs, Blood Banks, Hospitals And Clinics, Clinical Laboratories

Subsegments:

1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents

2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers

3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9838&type=smp

Which Regions Are Driving the Next Phase of the Immunoassay Market Growth?

North America was the largest region in the immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Market Trends and Innovations Are Shaping the Future of the Immunoassay Industry?

The adoption of progressive product enhancement is a leading trend in the immunoassay market. Firms that are prominent in this market are directing their efforts towards the creation of novel products to amplify their market presence. Getein Biotech Inc., a biotechnology company from China that deals in the production, retail, customer service, and R&D of in vitro diagnostic reagents and instruments, introduced MAGICL 6000 in MEDICA 2022, November. This state-of-the-art, compact chemiluminescence immunoassay analyzer, named MAGICL 6000, serves as the optimal choice for laboratories that need a single-step chemiluminescence solution with medium to high workflow requirements. The device has the advantage of being highly efficient and compact, provides fully automated functionality, and boasts the highest evaluation frequency among comparable-sized devices.

View the full report here:

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

How Is the Immunoassay Market Defined and What Are Its Core Parameters?

Immunoassay is a bioanalytical test that employs antibody attachment to antigens to detect and quantify specific chemicals. Diseases can be diagnosed using immunoassays. Furthermore, information from test findings concerning an illness may be used to establish a course of therapy. This technique relies primarily on a competitive binding response for a finite number of receptors on an extremely specific anti-analyte antibody between a set quantity of labeled versions of an analyte and a substantial portion of an unmarked sample analyte.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9838

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Immunoassay Market From 2025 To 2029?

In recent times, there has been a consistent expansion of the immunoassay market size. The forecasted growth is from $35.81 billion in 2024 to $37.32 billion in 2025, representing a compound annual growth rate (CAGR) of 4.2%. Factors such as disease prevalence, an aging population, outbreaks of infectious diseases, point-of-care testing, and enhanced research funding have contributed to the growth observed in the historical period.

The market size of immunoassays is anticipated to witness significant expansion in the coming years, flourishing to $49.4 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 7.3%. The anticipated growth during the forecast period can be credited to factors such as advancement in personalized medicine, growing presence in emerging markets, readiness for pandemics, cancer detection mechanisms, and transition towards at-home testing. Notable trends in the forecast duration include efforts towards regulatory harmonization, multi-use immunoassays, personalized assay solutions, association with wearable technologies, and downsizing of assays.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9838&type=smp

What Are the Core Market Drivers Propelling Growth in the Immunoassay Industry?

Anticipated growth in the immunoassay market is largely due to the rise in infectious and chronic health conditions. Typically defined as conditions that last a year or more and require regular medical attention, limit daily function, or both, chronic illnesses are on an upward trend. Furthermore, infectious diseases, resulting from organisms like bacteria, viruses, fungi, or parasites, are also contributing to this trend. Many of these organisms live on the human body and can cause various illnesses. Some of these infectious diseases can be transmitted between individuals. Immunoassays have a vital role in identifying these types of diseases. For example, research conducted by the American biomedical research organization, the National Institutes of Health (NIH), suggests an increase of 99.5% (from 71.522 million in 2020 to 142.66 million in 2050) in the number of individuals aged 50 or older with at least one chronic illness in the United States. Simultaneously, they project an increase from 7.8304 million in 2020 to 14.968 million in 2050 in people suffering from multiple health conditions, marking a 91.16% rise. Hence, the growing prevalence of infectious and chronic diseases is fueling the immunoassay market’s growth.

How Is the Immunoassay Market Segmented?

The immunoassaymarket covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End User: Research And Academic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies And CROs, Blood Banks, Hospitals And Clinics, Clinical Laboratories

Subsegments:

1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents

2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers

3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9838&type=smp

Which Regions Are Driving the Next Phase of the Immunoassay Market Growth?

North America was the largest region in the immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Market Trends and Innovations Are Shaping the Future of the Immunoassay Industry?

The adoption of progressive product enhancement is a leading trend in the immunoassay market. Firms that are prominent in this market are directing their efforts towards the creation of novel products to amplify their market presence. Getein Biotech Inc., a biotechnology company from China that deals in the production, retail, customer service, and R&D of in vitro diagnostic reagents and instruments, introduced MAGICL 6000 in MEDICA 2022, November. This state-of-the-art, compact chemiluminescence immunoassay analyzer, named MAGICL 6000, serves as the optimal choice for laboratories that need a single-step chemiluminescence solution with medium to high workflow requirements. The device has the advantage of being highly efficient and compact, provides fully automated functionality, and boasts the highest evaluation frequency among comparable-sized devices.

View the full report here:

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

How Is the Immunoassay Market Defined and What Are Its Core Parameters?

Immunoassay is a bioanalytical test that employs antibody attachment to antigens to detect and quantify specific chemicals. Diseases can be diagnosed using immunoassays. Furthermore, information from test findings concerning an illness may be used to establish a course of therapy. This technique relies primarily on a competitive binding response for a finite number of receptors on an extremely specific anti-analyte antibody between a set quantity of labeled versions of an analyte and a substantial portion of an unmarked sample analyte.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9838

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model